<b>Conclusions:</b> Tumor cell <i>CEBPB</i> expression, up-regulated by <i>TP53</i> mutation, can increase <i>CTLA4</i> expression in T cells and negatively affect patient outcomes. This evidence concerns the gene CTLA4 and neoplasm.